World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2017; 23(43): 7735-7745 [PMID: 29209114 DOI: 10.3748/wjg.v23.i43.7735]
URL:	https://www.wjgnet.com/1007-9327/full/v23/i43/7735.htm

Number	Citing Articles
1	Xiufeng Liu, Feng Xia, Yue Chen, Huichuan Sun, Zhengqiang Yang, Bo Chen, Ming Zhao, Xinyu Bi, Tao Peng, Aizier Ainiwaer, Zhiwen Luo, Fusheng Wang, Yinying Lu. Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition). Liver Research 2024; 8(2): 61 doi: 10.1016/j.livres.2024.05.001
2	Chai Hong Rim, Sunmin Park, In-Soo Shin, Won Sup Yoon. Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis. Cancers 2021; 13(12): 2912 doi: 10.3390/cancers13122912
3	Fu-Quan Liu, Tao Wang, Fu-Liang He, Zhen-Hua Fan, Lei Wang, Hong-Wei Zhao, Zhen-Dong Yue, Yi-Fan Wu, Yue Zhang. Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus. World Journal of Gastrointestinal Oncology 2019; 11(4): 310-321 doi: 10.4251/wjgo.v11.i4.310 Abstract(1331) \| Core Tip(1705) \| Full Article(HTML)(4854) \| Full Article (PDF)-2423K(764) \| Full Article (Word)-1098K(304) \| Audio-1933K(17) \| Peer-Review Report-175K(279) \| Answering Reviewers-53K(328) \| Times Cited (6) \| Total Visits (19375) \| Open
4	Lin Wang, Hou Gu, Zhi-Xian Zhang, Jie Lin, Zhi-Tian Shi, Xue-Song Wu, Hao-Ran Tang, Tian-Hao Bao, Yang Ke, Xue-Fen Lei. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study. World Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74 Abstract(1645) \| Core Tip(1556) \| Full Article(HTML)(4346) \| Full Article (PDF)-1408K(840) \| Full Article (Word)-423K(428) \| Audio-1944K(26) \| Peer-Review Report-149K(363) \| Answering Reviewers-329K(479) \| Times Cited (11) \| Total Visits (23494) \| Open
5	Zi-Han Zhang, Wen Zhang, Qing-Xin Liu, Jing-Qin Ma, Min-Jie Yang, Ling-Xiao Liu, Jian-Jun Luo, Zhi-Ping Yan. Embolization of the Transhepatic Tract after Percutaneous Portal Vein Interventions: Single-Centre Retrospective Study Comparing n-butyl Cyanoacrylate Versus Coils. CardioVascular and Interventional Radiology 2021; 44(11): 1728 doi: 10.1007/s00270-021-02883-5
6	Lei Zhang, Bo Hu, Wei Li, Peng Huang, Shen Zhang, Bin-Yan Zhong, Cai-Fang Ni. 125I Irradiation Stent for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis: A Systematic Review. CardioVascular and Interventional Radiology 2020; 43(2): 196 doi: 10.1007/s00270-019-02346-y
7	Bei Wu, Guowen Yin, Xu He, Guoping Chen, Boxiang Zhao, Jinhua Song, Jianping Gu. Endovascular Treatment of Cancer-Associated Venous Obstruction: Comparison of Efficacy Between Stent Alone and Stent Combined With Linear Radioactive Seeds Strand. Vascular and Endovascular Surgery 2020; 54(7): 565 doi: 10.1177/1538574420939747
8	Sorafenib. Reactions Weekly 2018; 1717(1): 252 doi: 10.1007/s40278-018-51322-1
9	Nan Du, Jingqin Ma, Zihan Zhang, Yongjie Zhou, Minjie Yang, Wen Zhang, Jianjun Luo, Zhiping Yan. Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00128
10	Nathalie Arendt, Tania Payo-Serafín, Anna Kolosenko, Maria Kopsida, Markus Sjöblom, Femke Heindryckx. Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients. Therapeutic Advances in Medical Oncology 2026; 18 doi: 10.1177/17588359261442686
11	Jun-Hao Mei, Kai-Zhi Jia, Kai Zhang, Zhi-Cheng Jin, Wei-Fu Lv, Zheng-Gang Ren, Jia-Liang Zheng, Yu-Liang Li, Zhong-Min Wang, Yong Li, Wei-Xin Ren, Wei-Dong Wang, Jian-Song Ji, Yue Liu, Zhong-Kai Wang, Cheng Feng, Tian Huang, Xia-Xing Bai, Xue Han, Tong Sun, Jin-He Guo, Gao-Jun Teng, Jian Lu. 125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulation. International Journal of Surgery 2026; 112(3): 7698 doi: 10.1097/JS9.0000000000004390
12	Jinliang Zhang, Xihao Zhang, Han Mu, Ge Yu, Wenge Xing, Lu Wang, Ti Zhang. Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.729764
13	Duo Hong, Yi Zhou, Xiaoting Wan, Hongying Su, Haibo Shao. Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08680-0
14	Jia-Wen Lin, Shen Zhang, Jian Shen, Yu Yin, Jun Yang, Cai-Fang Ni, Wan-Sheng Wang. The efficacy of transarterial chemoembolization combined with helical iodine-125 seed implant, lenvatinib and PD-1 inhibitors in patients with hepatocellular carcinoma complicated by main portal vein tumor thrombus: a retrospective study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1514375
15	Abdul Rehman Khan, Xuyong Wei, Xiao Xu. Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma – The Changing Tides. Journal of Hepatocellular Carcinoma 2021; : 1089 doi: 10.2147/JHC.S318070
16	Kaihao Xu, Chuan Tian, Yiming Liu, Kunpeng Wu, Dechao Jiao, Xinwei Han. Is iodine-125 seed strand brachytherapy suitable for ureteral carcinoma?. Urologic Oncology: Seminars and Original Investigations 2022; 40(12): 537.e11 doi: 10.1016/j.urolonc.2022.08.009
17	Fangzhou Luo, Mengxia Li, Jun Ding, Shusen Zheng. The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.635731
18	Wei Huang, Ju Gong, Qingbing Wang, Ziyin Wang, Qin Liu, Jingjing Liu, Junwei Gu, Xiaoyi Ding, Zhiyuan Wu. Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.973357
19	Israa Alhashimi, Abeer Abdullah Hamid, Dana Elkhalifa, Sohaib Zoghoul, Ali Barah, Mohamed Izham Mohamed Ibrahim. Evaluating the Efficacy and Safety of TACE Combined with Iodine-125 Brachytherapy Versus TACE Monotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2026; 15(6): 2267 doi: 10.3390/jcm15062267
20	Jian-Hua Fu, Jian-Yun Li, Wei-Fan Sui. Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis. World Journal of Clinical Oncology 2024; 15(3): 447-455 doi: 10.5306/wjco.v15.i3.447 Abstract(653) \| Core Tip(746) \| Full Article(HTML)(1650) \| Full Article with Cover (PDF)-3038K(166) \| Audio-1003K(13) \| Peer-Review Report-170K(132) \| Answering Reviewers-88K(122) \| Full Article (PDF)-2725K(223) \| Full Article (XML)-65K(113) \| Times Cited (4) \| Total Visits (7119) \| Open
21	Zi-Han Zhang, Si-Nan Hou, Jia-Ze Yu, Wen Zhang, Jing-Qin Ma, Min-Jie Yang, Qing-Xin Liu, Ling-Xiao Liu, Jian-Jun Luo, Xu-Dong Qu, Zhi-Ping Yan. Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1086095
22	Walaa Abdelhamed, Hend Shousha, Mohamed El-Kassas. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?. Liver Research 2024; 8(3): 141 doi: 10.1016/j.livres.2024.09.002
23	Puja Sahai, Hanuman Prasad Yadav, Ashok Choudhury, Saggere Muralikrishna Shasthry, Ankur Jindal, Aprajita Mall, Amar Mukund, Yashwant Patidar, Mangu Srinivas Bharadwaj, Bangkim Chandra Khangembam, Guresh Kumar, Archana Rastogi, Viniyendra Pamecha. Outcomes with radiotherapy in multimodality treatment for hepatocellular carcinoma with portal vein tumour thrombosis. BJR\|Open 2024; 7(1) doi: 10.1093/bjro/tzaf002
24	Nathalie Arendt, Maria Kopsida, Jaafar Khaled, Markus Sjöblom, Femke Heindryckx. Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients. Therapeutic Advances in Medical Oncology 2025; 17 doi: 10.1177/17588359251316663
25	Jian Lu, Jin-He Guo, Jian-Song Ji, Yu-Liang Li, Wei-Fu Lv, Hai-Dong Zhu, Jun-Hui Sun, Wei-Xin Ren, Fu-Jun Zhang, Wei-Dong Wang, Hai-Bo Shao, Guang-Shao Cao, Hai-Liang Li, Kun Gao, Po Yang, Guo-Wen Yin, Guang-Yu Zhu, Fa-Zong Wu, Wu-Jie Wang, Dong Lu, Sheng-Qun Chen, Jie Min, Yang Zhao, Rui Li, Li-Gong Lu, Wan Yee Lau, Gao-Jun Teng. Irradiation stent with 125I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial. International Journal of Surgery 2023; 109(5): 1188 doi: 10.1097/JS9.0000000000000295
26	Tong-Guo Miao, Shi-Ya Zhang, Yun-Jing Zhang, Dong Ma, Yue-Min Nan. Combined DeRitis ratio and alkaline phosphatase on the prediction of portal vein tumor thrombosis in patients with hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72291-5